Takeda Pharmaceutical Company Limited Announces Zasocitinib Delivers Rapid and Durable Skin Clearance in Plaque Psoriasis
Takeda Pharmaceutical Company Limited announced new data from the two pivotal Phase 3 studies of zasocitinib , a next-generation, highly selective oral tyrosine kinase 2 inhibitor, in adults with...